- Acumen Powered by Robins Kaplan LLP®
- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Entertainment and Media Litigation
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Fiduciary Disputes
Acumen Powered by Robins Kaplan LLP®
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
-
November 11, 2024Tommy Du Honored With 2024 Sheila Sonenshine Associate Pro Bono Award
-
November 7, 2024Robins Kaplan Achieves National Tier 1 Rankings in Multiple Practice Areas on 2025 Best Law Firms List
-
November 1, 2024Robins Kaplan Recognized for “Tipping the Scales” by Diversity & Flexibility Alliance
-
November 14, 2024Roots, Branches, and Wings: Risks and Rewards of Generational Wealth
-
November 18, 2024Careers in Litigation
-
December 11, 20242024 Year in Review: eDiscovery and Artificial Intelligence
-
November 8, 2024Destination Skiing And The DOJ's Mountain Merger Challenge
-
November 6, 2024How Recent Patent Damages Precedent May Increase Reasonable Royalty Awards
-
September 2024Meet Our New Partner and Trial Advocacy Seminar Keynote Speaker: B. Todd Jones
-
September 16, 2022Uber Company Systems Compromised by Widespread Cyber Hack
-
September 15, 2022US Averts Rail Workers Strike With Last-Minute Tentative Deal
-
September 14, 2022Hotter-Than-Expected August Inflation Prompts Massive Wall Street Selloff
Find additional firm contact information for press inquiries.
Find resources to help navigate legal and business complexities.
Elizabeth Gardner
Elizabeth Gardner
Of Counsel
Experience
For more than 20 years, Elizabeth Gardner has helped guide clients through all phases of litigation involving patented and trade secret protected technology. She advises clients on which cases are worth pursuing and which are worth settling, and excels in finding creative business solutions along the way.
Ms. Gardner represents clients in a broad range of technology areas, including in the chemical, materials, pharmaceutical, electrical, medical products, and medical diagnostics industries. She has represented clients in numerous Patent Trial and Appeal Board (PTAB) proceedings, as well as in patent jury trials, bench trials, in federal district courts and at the International Trade Commission, and in appeals to the Court of Appeals for the Federal Circuit.
In addition to her trial work, Ms. Gardner has counseled clients on negotiating and drafting licensing agreements and has advised on issues related to patentability, validity, and infringement.
Serving as lead defense counsel, reached a confidential and amicable settlement on behalf of a multinational materials technology company in a multi-jurisdictional trade secret and breach of contract litigation brought by a competitor. Dispute related to an M&A transaction under which Defendant had purchased certain business assets from Plaintiff. At stake were the Defendant’s rights to develop and introduce emissions control catalyst products into a growing, global market. Served as lead counsel in the U.S. litigation as well as in the arbitration that was pending in Sweden at the time of resolution.
Represented Medinol in the assertion of patents relating to coronary stents against Cordis and Johnson & Johnson in the Southern District of New York. (Prior to joining Robins Kaplan LLP)
Represented Umicore in multiple Inter Parties Review proceedings instituted by the United States Patent and Trademark Office challenging the validity of patents owned by competitor BASF Corporation, claiming catalysts and diesel exhaust gas treatment systems. (Prior to joining Robins Kaplan LLP)
Represented Covidien in defense of its single incision laparoscopic access device against patent infringement claims brought by Applied Medical in the Central District of California. (Prior to joining Robins Kaplan LLP)
Represented Organon and Biotechnology General in the assertion of patent claims protecting Organon's branded MIRCETTE® product against Barr and Duramed's generic oral contraceptive. (Prior to joining Robins Kaplan LLP)
Represented Barnes & Noble in defense of its NOOK® eReader against claims brought by Microsoft Corporation in the ITC for infringement of patents relating to computer software. (Prior to joining Robins Kaplan LLP)
Represented the Heirs of Richard Ritchie, the formulator of Pepsi Cola, against Pepsico, Inc. concerning the heirs' ownership of certain documents and intellectual property relating to Pepsi Cola. (Prior to joining Robins Kaplan LLP)
- Named a “Litigation Star,” Benchmark Litigation (2021-2025 editions)
- Named a “National Practice Area Star,” Benchmark Litigation (2023)
- Named a “Patent Star,” Managing Intellectual Property (2019-2024)
- Recognized as New York “IP Star” by Managing Intellectual Property
- Named one of the “Top 250 Women in IP” by Managing Intellectual Property
- Listed as a “Recommended Individual for Litigation in New York,” IAM 1000: The World’s Leading Patent Professionals (2020-2024)
- New York
- U.S. Court of Appeals, Federal Circuit
- U.S. District Court, Eastern District of New York
- U.S. District Court, Southern District of New York
- University of Michigan Law School, J.D. (1991)
- Columbia University, M.S. in Materials Science (1988)
- Columbia University, B.S. in Materials Science (1986)
- American Bar Association
- New York Intellectual Property Law Association
-
The New Art of Advocacy
Panelist, Robins Kaplan LLP Medtronic MP3 CLE, Webinar (October 13, 2020)
RESOURCES
NEWS
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.